FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2796780719> ?p ?o ?g. }

• W2796780719 endingPage "448" @default.
• W2796780719 startingPage "438" @default.
• W2796780719 abstract "The CIGMA study investigated a novel human polyclonal antibody preparation (trimodulin) containing ~ 23% immunoglobulin (Ig) M, ~ 21% IgA, and ~ 56% IgG as add-on therapy for patients with severe community-acquired pneumonia (sCAP). In this double-blind, phase II study (NCT01420744), 160 patients with sCAP requiring invasive mechanical ventilation were randomized (1:1) to trimodulin (42 mg IgM/kg/day) or placebo for five consecutive days. Primary endpoint was ventilator-free days (VFDs). Secondary endpoints included 28-day all-cause and pneumonia-related mortality. Safety and tolerability were monitored. Exploratory post hoc analyses were performed in subsets stratified by baseline C-reactive protein (CRP; ≥ 70 mg/L) and/or IgM (≤ 0.8 g/L). Overall, there was no statistically significant difference in VFDs between trimodulin (mean 11.0, median 11 [n = 81]) and placebo (mean 9.6; median 8 [n = 79]; p = 0.173). Twenty-eight-day all-cause mortality was 22.2% vs. 27.8%, respectively (p = 0.465). Time to discharge from intensive care unit and mean duration of hospitalization were comparable between groups. Adverse-event incidences were comparable. Post hoc subset analyses, which included the majority of patients (58–78%), showed significant reductions in all-cause mortality (trimodulin vs. placebo) in patients with high CRP, low IgM, and high CRP/low IgM at baseline. No significant differences were found in VFDs and mortality between trimodulin and placebo groups. Post hoc analyses supported improved outcome regarding mortality with trimodulin in subsets of patients with elevated CRP, reduced IgM, or both. These findings warrant further investigation. Trial registration: NCT01420744." @default.
• W2796780719 created "2018-04-24" @default.
• W2796780719 creator A5002244120 @default.
• W2796780719 creator A5002389347 @default.
• W2796780719 creator A5002723718 @default.
• W2796780719 creator A5003097810 @default.
• W2796780719 creator A5003379719 @default.
• W2796780719 creator A5006917212 @default.
• W2796780719 creator A5008447327 @default.
• W2796780719 creator A5010235945 @default.
• W2796780719 creator A5012228981 @default.
• W2796780719 creator A5023118976 @default.
• W2796780719 creator A5023128205 @default.
• W2796780719 creator A5025379878 @default.
• W2796780719 creator A5028623546 @default.
• W2796780719 creator A5029470208 @default.
• W2796780719 creator A5029917264 @default.
• W2796780719 creator A5031567638 @default.
• W2796780719 creator A5033115927 @default.
• W2796780719 creator A5034004394 @default.
• W2796780719 creator A5040504112 @default.
• W2796780719 creator A5041913275 @default.
• W2796780719 creator A5042072678 @default.
• W2796780719 creator A5052178369 @default.
• W2796780719 creator A5052549188 @default.
• W2796780719 creator A5057363437 @default.
• W2796780719 creator A5059857876 @default.
• W2796780719 creator A5062307458 @default.
• W2796780719 creator A5063159010 @default.
• W2796780719 creator A5063910272 @default.
• W2796780719 creator A5066504880 @default.
• W2796780719 creator A5067054471 @default.
• W2796780719 creator A5067807477 @default.
• W2796780719 creator A5068778977 @default.
• W2796780719 creator A5069955660 @default.
• W2796780719 creator A5074204143 @default.
• W2796780719 creator A5075236355 @default.
• W2796780719 creator A5075445891 @default.
• W2796780719 creator A5077836225 @default.
• W2796780719 creator A5079018056 @default.
• W2796780719 creator A5079436078 @default.
• W2796780719 creator A5086478476 @default.
• W2796780719 creator A5088100489 @default.
• W2796780719 creator A5089266213 @default.
• W2796780719 creator A5091232848 @default.
• W2796780719 date "2018-04-01" @default.
• W2796780719 modified "2023-10-18" @default.
• W2796780719 title "Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)" @default.
• W2796780719 cites W1498847688 @default.
• W2796780719 cites W1592150097 @default.
• W2796780719 cites W1748070847 @default.
• W2796780719 cites W1922984966 @default.
• W2796780719 cites W1978960863 @default.
• W2796780719 cites W2000714505 @default.
• W2796780719 cites W2011825836 @default.
• W2796780719 cites W2013976365 @default.
• W2796780719 cites W2041783524 @default.
• W2796780719 cites W2046613841 @default.
• W2796780719 cites W2068904704 @default.
• W2796780719 cites W2076274573 @default.
• W2796780719 cites W2079558011 @default.
• W2796780719 cites W2097162201 @default.
• W2796780719 cites W2100459766 @default.
• W2796780719 cites W2101947610 @default.
• W2796780719 cites W2105981152 @default.
• W2796780719 cites W2107354258 @default.
• W2796780719 cites W2122415095 @default.
• W2796780719 cites W2124519382 @default.
• W2796780719 cites W2133979383 @default.
• W2796780719 cites W2142413409 @default.
• W2796780719 cites W2155965977 @default.
• W2796780719 cites W2156802529 @default.
• W2796780719 cites W2166607382 @default.
• W2796780719 cites W2173625382 @default.
• W2796780719 cites W2557430728 @default.
• W2796780719 cites W2563657286 @default.
• W2796780719 cites W4232527057 @default.
• W2796780719 cites W2151053406 @default.
• W2796780719 doi "https://doi.org/10.1007/s00134-018-5143-7" @default.
• W2796780719 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5924663" @default.
• W2796780719 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29632995" @default.
• W2796780719 hasPublicationYear "2018" @default.
• W2796780719 type Work @default.
• W2796780719 sameAs 2796780719 @default.
• W2796780719 citedByCount "87" @default.
• W2796780719 countsByYear W27967807192018 @default.
• W2796780719 countsByYear W27967807192019 @default.
• W2796780719 countsByYear W27967807192020 @default.
• W2796780719 countsByYear W27967807192021 @default.
• W2796780719 countsByYear W27967807192022 @default.
• W2796780719 countsByYear W27967807192023 @default.
• W2796780719 crossrefType "journal-article" @default.
• W2796780719 hasAuthorship W2796780719A5002244120 @default.
• W2796780719 hasAuthorship W2796780719A5002389347 @default.
• W2796780719 hasAuthorship W2796780719A5002723718 @default.
• W2796780719 hasAuthorship W2796780719A5003097810 @default.
• W2796780719 hasAuthorship W2796780719A5003379719 @default.
• W2796780719 hasAuthorship W2796780719A5006917212 @default.

• next